Hemophilia A

6 protocols meet the specified criteria

OCR14675

Phase 3, prospective, multi-center, open label study to investigate safety, immunogenicity, and hemostatic efficacy of PEGylated Factor VIII (BAX 855) in previously untreated patients (PUPs) < 6 years with severe hemophilia A (FVIII < 1%)

OCR15074

A Randomized, Multicenter, Open-Label, Phase III Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Patients Without Inhibitors

OCR15335

Evaluation of Joint Arthropathy Using Ultrasound Technique in Children With Severe Hemophilia Undergoing Prophylaxis Regimen

OCR17544

A Phase IV Multicenter, Single-Arm, Open Label Study of Emicizumab Prophylaxis in Patients with Hemophilia A and Inhibitors Undergoing Minor Surgical Procedures.

OCR18775

A Prospective Non-Interventional Study of Bleeding Episodes, Factor VIII Infusions, and Patient-Reported Outcomes in Individuals with Severe Hemophilia A

OCR19677

ATHN 2 - A Longitudinal, Observational Study of Previously Treated Hemophilia Patients Switching Factor Replacement Products